Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia. - Wikidata - awgldk - TriplyDB

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.

http://www.wikidata.org/entity/Q37002149

about

Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia.Therapy-related myeloid neoplasms: clinical perspectives

P2860

Q42699937-288421E6-2E5A-47E2-AE78-BB7CA3A3D9BE Q57074546-0872CA42-CE30-4512-8731-7F4C58EEC437

P2860

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.

http://www.wikidata.org/entity/Q37002149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@en

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@nl

type

label

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@en

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@nl

prefLabel

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@en

Effect of therapy-related acut ...... s with acute myeloid leukemia.

@nl

P1433

Q37002149-3F0F1E65-6494-4E4D-920E-B5DBCE094A53

P1476

Q37002149-B5EF9237-B7F3-453C-9569-ABFF5AC88393

P2093

Q37002149-1874F650-1A0B-4D8D-8D3B-8F7FE144D575

Q37002149-3DE7D30A-CEED-4CE5-9AB0-E52418977DC4

Q37002149-4D41B288-E9BF-4290-9E67-A9864E364715

Q37002149-4F389EAE-5E8D-4332-90A6-CC58C75673AB

Q37002149-5B0E62C5-8600-4832-A829-0E04F3CE1007

Q37002149-5BE6ACF9-ADF8-4F29-AC39-E282BB710301

Q37002149-5FC5385A-D41D-458E-A54E-00F95A68A47E

Q37002149-69AB5DE1-18A9-4600-8B01-64FF98476B8F

Q37002149-7A673ADA-FBED-491F-AA48-AA338D1D8294

Q37002149-962B3E2B-CE0F-43E2-8FA6-BFA0EB930EE5

P2860

Q37002149-04098120-3F47-47D0-929E-5F7BD1BCD711

Q37002149-0942A4C0-10FA-4C81-AB6C-9D15708F8A7B

Q37002149-0CFFF146-5C70-480F-9E46-1585AF1680B7

Q37002149-10CB98E5-7029-4B6B-8D2A-3F51473DB39F

Q37002149-27115482-C8F7-49AE-A1F2-BB2D3D897DCF

Q37002149-27694EBB-6E22-4B59-970B-DAB288C1D9BF

Q37002149-2B02FC8B-0DD6-4ED7-BF14-902BD114CB75

Q37002149-2C375BF7-0E2E-4CAC-8BFB-0441BDD3E492

Q37002149-301CE13D-EC72-4385-B114-665637A329AE

Q37002149-324E7973-056B-4523-920D-0D04363D7236

P304

Q37002149-FA736B41-20B8-4436-9A28-421F04AC39C5

P31

Q37002149-B415B1E9-7ECD-4480-9FBC-5900885A8A31

P356

Q37002149-100A5BBC-8B7D-4BA9-937C-88C23E161949

P433

Q37002149-CBC1CE49-4AF7-42F5-BA61-A33453E6F1BD

P478

Q37002149-42DCD6C8-B365-4FDA-8D88-13DF96648446

P50

Q37002149-2E7C1CBD-575D-420B-84B0-484F57D5E83D

Q37002149-46BAD20F-806F-4487-9107-44B0E6DD1FD2

P577

Q37002149-4A8477A8-3F08-40D6-B9DB-750A55DD7777

P5875

Q37002149-99B4895D-94DF-4A09-A3AD-5506FA04EE27

P698

Q37002149-C06DFBEE-D9E0-436E-A2AE-789D71C6C2B4

P921

Q37002149-7798D243-082C-45D5-9519-1EE3BFA9729A

Q37002149-8BA59BDD-66A5-4167-925C-9DB3FE3846FF

P932

Q37002149-FA128F93-B74D-4992-99CA-78C55DEED134

P356

P1433

Oncology Letters

P1476

Effect of therapy-related acut ...... ts with acute myeloid leukemia

@en

P2093

Ana Espírito ESPíRITO Santo

http://www.w3.org/2001/XMLSchema#string

Angelo Martins

http://www.w3.org/2001/XMLSchema#string

Claudia Moreira

http://www.w3.org/2001/XMLSchema#string

Dulcineia Pereira

http://www.w3.org/2001/XMLSchema#string

Ilídia Moreira

http://www.w3.org/2001/XMLSchema#string

Isabel Ferreira

http://www.w3.org/2001/XMLSchema#string

Isabel Oliveira

http://www.w3.org/2001/XMLSchema#string

José Mário Mariz

http://www.w3.org/2001/XMLSchema#string

Luís Leite

http://www.w3.org/2001/XMLSchema#string

Luísa Viterbo

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cancer treatment and survivorship statistics, 2012

Cancer statistics, 2014

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

The World Health Organization (WHO) classification of the myeloid neoplasms

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.

The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy

Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.

P304

262-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4591

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

303316493

http://www.w3.org/2001/XMLSchema#string

P698

27347135

http://www.w3.org/2001/XMLSchema#string

P921

therapy-related acute myeloid leukemia

P932

4907087

http://www.w3.org/2001/XMLSchema#string